Daiichi Life Insurance Co. Ltd. Makes New Investment in Humana Inc. $HUM

Daiichi Life Insurance Co. Ltd. bought a new stake in Humana Inc. (NYSE:HUM) during the 2nd quarter, HoldingsChannel reports. The fund bought 2,467 shares of the insurance provider’s stock, valued at approximately $980,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Commerce Bank bought a new stake in shares of Humana during the 2nd quarter worth approximately $1,534,000. Northwestern Mutual Wealth Management Co. bought a new position in Humana in the second quarter valued at approximately $1,122,000. Evolve Private Wealth LLC bought a new position in Humana in the second quarter valued at approximately $278,000. Westpac Banking Corp acquired a new position in Humana during the second quarter valued at approximately $230,000. Finally, William Blair Investment Management LLC acquired a new position in Humana during the second quarter valued at approximately $13,569,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on HUM. Lake Street Capital started coverage on Humana in a report on Thursday, July 30th. They issued a “buy” rating on the stock. JPMorgan Chase & Co. boosted their price target on Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a report on Monday, August 10th. UBS Group assumed coverage on Humana in a research report on Thursday, July 30th. They set a “buy” rating for the company. Seaport Research Partners lowered Humana to a “neutral” rating in a research note on Wednesday, May 20th. Finally, Zacks Research cut Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 11th. Fourteen analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $403.91.

Humana Stock Performance

Shares of Humana stock opened at $386.43 on Tuesday. The company’s 50 day moving average price is $383.50 and its two-hundred day moving average price is $283.61. The firm has a market capitalization of $46.40 billion, a P/E ratio of 36.56, a P/E/G ratio of 2.17 and a beta of 0.72. Humana Inc. has a fifty-two week low of $163.11 and a fifty-two week high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter last year, the business posted $6.27 EPS. On average, equities analysts forecast that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.